Insider / ORACLE CORP
Maxson Hilary B
Chief Financial Officer at ORACLE CORP
- Company
- ORACLE CORP
- Ticker
- ORCL
- First filing on record
- May 7, 2026
- Latest trade on record
- October 15, 2026
- SEC filings
- EDGAR ↗
Maxson Hilary B, Chief Financial Officer at ORACLE CORP, has disclosed 3 transactions in ORCL since May 7, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $41.6M at the reported prices. The latest was filed October 19, 2026, 4 days after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Maxson Hilary B reported 3 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 2 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 3 | 369,792 | $41.6M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 3 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ORCL | Other A | October 15, 2026 | October 19, 2026 | 4d | 89,240 | — | — | derivative | Form 4 ↗ | |
| ORCL | Other A | May 5, 2026 | May 7, 2026 | 2d | 56,111 | — | — | derivative | Form 4 ↗ | |
| ORCL | Other A | May 5, 2026 | May 7, 2026 | 2d | 224,441 | $185 | $41.6M | derivative | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 19, 2026 | Form 4 | 0001341439-26-000113 | 1 | published | EDGAR ↗ |
| May 7, 2026 | Form 4 | 0001341439-26-000034 | 2 | published | EDGAR ↗ |
Other insiders at ORACLE CORP
- HENLEY JEFFREY Vice Chairman 30 rows
- Smith Maria EVP, Chief Accounting Officer 17 rows
- Levey Stuart EVP, Chief Legal Officer 14 rows
- Hura Mark Pres., Global Field Operations 13 rows
- Magouyrk Clayton M. Chief Executive Officer 13 rows
- Sicilia Michael D. Chief Executive Officer 12 rows
- BERG JEFFREY Director 7 rows
- CATZ SAFRA Chief Executive Officer 5 rows
- MOORMAN CHARLES W Director 5 rows
- Ablo Awo Director 4 rows
Everyone on file, with contracts and lobbying under the company's name: ORACLE CORP.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 2 | 3 | May 7, 2026 | October 19, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.